analyt
perform
new
aler
tm
influenza
b
kit
alflu
assay
base
isotherm
nucleic
acid
amplif
evalu
compar
antigen
detect
method
sd
biolin
influenza
viru
antigen
test
sdb
autom
realtim
rtpcr
simplexa
tm
flu
ab
vr
direct
assay
spx
detect
influenza
virus
inhous
rtpcr
use
refer
method
sensit
alflu
sdb
spx
respect
specif
techniqu
turnaround
time
min
alflu
min
sdb
min
spx
aler
tm
influenza
b
assay
optim
pointofcar
assay
influenza
diagnosi
clinic
emerg
set
sensit
specif
antigen
detect
method
palabra
clave
gripe
molecular
r
e
u
e
n
se
el
nuevo
ensayo
aler
tm
influenza
b
kit
alflu
basado
en
la
de
nucleico
se
con
un
de
de
sd
biolin
influenza
viru
antigen
test
sdb
con
una
rtpcr
en
tiempo
real
simplexa
tm
flu
ab
vr
direct
assay
spx
para
la
de
viru
de
la
gripe
se
una
rtpcr
en
tiempo
real
casera
como
de
referencia
la
sensibilidad
de
alflu
sdb
spx
fue
del
del
del
respectivament
se
obtuvo
una
especificidad
del
con
todo
lo
el
tiempo
de
fue
de
min
para
alflu
de
min
para
sdb
de
min
para
spx
el
ensayo
aler
tm
influenza
b
es
para
el
de
gripe
en
unidad
de
urgencia
al
ser
sensibl
que
la
de
de
rapid
influenza
antigen
detect
test
radt
recommend
pointofcar
tool
influenza
viru
flu
detect
howev
shown
variabl
sensit
neg
result
radt
exclud
infect
requir
confirm
sensit
method
autom
nucleic
acid
amplif
test
naat
base
realtim
revers
transcriptasepcr
rrtpcr
current
avail
although
highli
sensit
expens
requir
longer
turnaround
time
radt
new
aler
tm
influenza
b
kit
alflu
aler
scarborough
scarborough
shown
excel
sensit
specif
valu
compar
viral
cultur
although
variabl
perform
compar
naat
amplif
technolog
intend
direct
specimen
test
provid
result
min
minim
handson
time
studi
analyt
perform
alflu
compar
immunochromatograph
radt
autom
rrtpcr
retrospect
studi
conduct
specimen
nasopharyng
aspir
nasopharyng
swab
bronchial
aspir
conserv
c
patient
acut
respiratori
tract
infect
period
fluposit
sampl
n
previous
character
flu
n
flu
b
n
either
inhous
rrtpcr
hrrtpcr
flu
aposit
sampl
subsequ
subtyp
n
n
previous
describ
modifi
primer
att
act
gga
cac
tag
tag
gca
ttt
ctt
tcc
att
gcg
aat
taqman
probe
aag
caa
ctg
gaa
atc
tag
tgg
tac
studi
protocol
carri
accord
declar
helsinki
nonintervent
studi
addit
investig
routin
procedur
addit
sampl
modif
physician
prescript
perform
data
analys
carri
use
anonym
databas
data
analyz
spss
softwar
spss
inc
chicago
il
sensit
specif
posit
ppv
neg
predict
valu
npv
confid
interv
ci
method
determin
twobytwo
concord
estim
cohen
kappa
coeffici
agreement
k
mean
c
valu
hrrtpcr
posit
falseneg
sampl
method
compar
mann
whitney
u
test
p
valu
consid
signific
hrrtpcr
carri
thaw
sampl
posit
flu
virus
true
posit
neg
previous
posit
c
mean
standard
deviat
specif
ppv
test
fals
posit
result
obtain
method
flu
type
correctli
classifi
posit
sampl
inde
neg
sampl
hrrtpcr
previous
posit
routin
also
neg
alflu
sdb
spx
sensit
npv
alflu
sdb
spx
respect
tabl
tabl
analyt
c
mean
standard
deviat
posit
sampl
alflu
sdb
respect
c
mean
standard
deviat
fals
neg
sampl
alflu
sdb
respect
signific
differ
mean
c
valu
posit
neg
sampl
alflu
sdb
observ
p
good
agreement
k
observ
alflu
spx
wherea
moder
k
weak
k
agreement
obtain
compar
sdb
alflu
spx
respect
total
turnaround
time
alflu
sdb
spx
min
respect
alflu
show
significantli
higher
sensit
sdb
flu
detect
requir
turnaround
time
superior
perform
alflu
compar
radt
previous
report
similar
result
recent
new
radt
demonstr
higher
sensit
immunochromatograph
assay
similar
one
demonstr
alflu
studi
howev
obtain
lower
sensit
alflu
previou
report
compar
assay
naat
base
pcr
may
reflect
variabl
viral
amount
sampl
among
studi
studi
semiquantifi
viral
load
c
measur
hrrtpcr
mean
c
higher
one
report
sampl
test
hurtado
et
al
demonstr
better
posit
percent
agreement
hrrtpcr
although
result
studi
may
compar
sinc
hrrtpcr
use
refer
method
probabl
differ
one
use
hurtado
et
al
observ
signific
differ
mean
c
posit
neg
sampl
alflu
result
sampl
c
hrrtpcr
would
like
give
fals
neg
result
although
high
viral
load
expect
patient
flu
laboratori
diagnosi
perform
within
h
onset
symptom
http
wwwcdcgovfluprofessionalsdiagnosismolecularassayshtm
delay
sampl
feasibl
especi
interepidem
period
situat
highli
sensit
method
necessari
achiev
reliabl
diagnosi
contrari
studi
demonstr
specif
contrast
report
investig
found
fals
posit
flu
type
error
costeffect
diagnost
algorithm
establish
base
clinic
featur
laboratori
resourc
flu
circul
document
geograph
region
clinic
diagnosi
could
enough
outpati
situat
flu
test
perform
special
situat
sever
case
andor
highrisk
condit
http
wwwcdcgov
fluprofessionalsdiagnosisclinician
guidanc
ridthtm
spx
alflu
demonstr
higher
sensit
sdb
due
speed
eas
use
alflu
may
optim
altern
radt
pointofcar
method
flu
detect
clinic
emerg
set
howev
neg
result
confirm
sensit
assay
hospit
patient
ensur
appropri
manag
treatment
